Taat Lifestyle & Wellness - CEO, Setti Coscarella
CEO, Setti Coscarella
Source: Tabacco Reporter
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • TAAT (TAAT) receives its first national mainstream media coverage in the US with an article published by Forbes profiling the company
  • The article details the value proposition of TAAT™ as an alternative to tobacco cigarettes due to its inherently non-addictive properties
  • TAAT™ Chief Executive Officer Setti Coscarella shares his professional background and journey to his current role at the company
  • The company will be hosting a live Q&A session with Mr. Coscarella on a Facebook Live stream at 9:15 am PST / 12:15 pm EST on Thursday, February 4
  • TAAT (TAAT) is up 6.54 per cent, trading at C$3.42 at 4 pm EST

TAAT (TAAT) receives its first national mainstream media coverage in the United States.

In addition to sharing his professional background with Forbes contributor Amanda Siebert, TAAT™ Chief Executive Officer Setti Coscarella, discusses TAAT’s partnership with packaged goods sales agency CROSSMARK.

Mr. Coscarella also details the value proposition of TAAT™ as an alternative to tobacco cigarettes and explains the strategy behind positioning TAAT™ as a tobacco category product to appeal to legal-aged smokers who could prefer a familiar product format. 

In regards to the article, Setti Coscarella commented, “Obtaining coverage of TAAT™ in a national mainstream news outlet such as Forbes is a tremendous milestone because it demonstrates positive reception and validation of TAAT™ as a company that is gaining momentum in the  $814 billion tobacco industry.

On behalf of the entire team, I can say we are very thankful for Amanda Siebert’s interest in the product and the company, and we hope this coverage helps to bring additional eyeballs of legal-aged smokers to TAAT™.”

The company will be hosting a live Q&A session with Mr. Coscarella on a Facebook Live stream at 9:15 am PST / 12:15 pm EST on Thursday, February 4, 2021. 

TAAT (TAAT) is up 6.54 per cent, trading at C$3.42 at 4 pm EST.

More From The Market Herald
Knight Therapeutics - President and CEO, Samira Sakhia.

" Knight Therapeutics (TSX:GUD) relaunches AKYNZEO in Brazil

Knight Therapeutics’ (GUD) affiliate United Medical has relaunched AKYNZEO in Brazil.

" Satellos Bioscience (TSXV:MSCL) changing the way we think of degenerative muscle diseases

Satellos Bioscience (MSCL) has filed a patent application with the US Patent and Trademark Office.

" NervGen Pharma (TSXV:NGEN) announces US$15M private placement

NervGen Pharma (NGEN) has announced a non-brokered private placement for gross proceeds of US$15,225,000.

" Feeding our plant-based future

One of the fastest-growing segments today is the plant-based industry, as the push towards cleaner lifestyles, eating habits, and sustainable living choices fuel